相似文献
1
Complete inhibition of food-stimulated gastric acid secretion by combined application of pirenzepine and ranitidine.
Gut. 1981 Jul;22(7):542-8. doi: 10.1136/gut.22.7.542.
2
Interactions of cimetidine and pirenzepine on peptone-stimulated gastric acid secretion in man.
Scand J Gastroenterol Suppl. 1980;66:103-14.
3
Inhibition of food stimulated acid secretion by association of pirenzepine and ranitidine in duodenal ulcer patients.
Int J Clin Pharmacol Ther Toxicol. 1986 Dec;24(12):685-8.
4
Simple approach to assess potentiated drug combinations in clinical trials: studies with pirenzepine plus H2-receptor antagonists.
Int J Clin Pharmacol Ther Toxicol. 1985 Jun;23(6):283-7.
5
[Effectiveness of cimetidine, pirenzepine and synthetic secretin on stimulated gastric acid secretion].
Z Gastroenterol. 1980 Jun;18(6):306-13.
6
The influence of various secretory inhibitors on peptic activity.
Scand J Gastroenterol Suppl. 1980;66:79-85.
7
Effects of ranitidine bismuth citrate on gastric acid secretion and gastrin release in subjects with and without Helicobacter pylori infection.
Aliment Pharmacol Ther. 1996 Dec;10(6):905-12. doi: 10.1046/j.1365-2036.1996.83255000.x.
8
Effect of pirenzepine and atropine on peptone meal-stimulated gastric secretion and plasma gastrin in healthy volunteers, patients with duodenal ulcer and vagotomized patients.
Digestion. 1985;32(4):267-72. doi: 10.1159/000199247.
9
[Effect of inhibitors of acid secretion in patients with duodenal ulcer. Comparative study of cimetidine, ranitidine and pirenzepine].
Rev Med Chil. 1984 Nov;112(11):1085-9.
10
Comparative study with ranitidine and cimetidine on gastric secretion in normal volunteers.
Gut. 1980 Sep;21(9):750-2. doi: 10.1136/gut.21.9.750.
引用本文的文献
1
Evaluation of antisecretory drug therapy of Zollinger-Ellison syndrome (ZES) using 24-hour pH monitoring.
Dig Dis Sci. 1983 Jul;28(7):577-84. doi: 10.1007/BF01299916.
2
Ranitidine: a review of its pharmacology and therapeutic use in peptic ulcer disease and other allied diseases.
Drugs. 1982 Oct;24(4):267-303. doi: 10.2165/00003495-198224040-00002.
3
Pirenzepine. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy in peptic ulcer disease and other allied diseases.
Drugs. 1985 Aug;30(2):85-126. doi: 10.2165/00003495-198530020-00001.
4
Effect of cimetidine and pirenzepine in combination on 24 hour intragastric acidity in subjects with previous duodenal ulceration.
Gut. 1986 Apr;27(4):428-32. doi: 10.1136/gut.27.4.428.
5
Telenzepine is at least 25 times more potent than pirenzepine--a dose response and comparative secretory study in man.
Gut. 1987 Jul;28(7):888-95. doi: 10.1136/gut.28.7.888.
6
Combined anti-muscarinic and H2 receptor blockade in the healing of refractory duodenal ulcer. A double blind study.
Gut. 1987 Nov;28(11):1505-9. doi: 10.1136/gut.28.11.1505.
7
Continuous intravenous infusions of famotidine maintain high intragastric pH in duodenal ulcer.
Gut. 1988 Apr;29(4):453-7. doi: 10.1136/gut.29.4.453.
8
Pharmacokinetic and pharmacodynamic studies in man simulating acute and chronic treatment with oral pirenzepine.
Eur J Clin Pharmacol. 1989;36(4):369-74. doi: 10.1007/BF00558297.
本文引用的文献
1
Optimal effective dose of anticholinergic drug in peptic ulcer therapy.
AMA Arch Intern Med. 1956 Apr;97(4):442-52. doi: 10.1001/archinte.1956.00250220062006.
2
A simple enzymatic procedure for radioimmunochemical quantitation of the large molecular forms of gastrin and cholecystokinin.
Anal Biochem. 1980 Feb;102(1):126-33. doi: 10.1016/0003-2697(80)90327-9.
3
Effects of pirenzepine and atropine on gastric secretory and plasma hormonal responses to sham-feeding in patients with duodenal ulcer.
Scand J Gastroenterol Suppl. 1980;66:63-9.
4
EEG and behavioral effects of pirenzepine in normal volunteers.
Scand J Gastroenterol Suppl. 1980;66:39-46.
5
Interactions of cimetidine and pirenzepine on peptone-stimulated gastric acid secretion in man.
Scand J Gastroenterol Suppl. 1980;66:103-14.
6
The effect of pirenzepine on meal-stimulated gastrointestinal hormones.
Scand J Gastroenterol Suppl. 1980;66:57-61.
7
Comparative study with ranitidine and cimetidine on gastric secretion in normal volunteers.
Gut. 1980 Sep;21(9):750-2. doi: 10.1136/gut.21.9.750.
8
Cimetidine and ranitidine in duodenal ulcer.
Br Med J. 1980 Aug 16;281(6238):473-4. doi: 10.1136/bmj.281.6238.473.
9
Ranitidine--a new H2-receptor antagonist.
Gut. 1980 Mar;21(3):187-91. doi: 10.1136/gut.21.3.187.
10
Comparison of ranitidine and cimetidine in the inhibition of histamine, sham-feeding, and meal-induced gastric secretion in duodenal ulcer patients.
Gut. 1980 Mar;21(3):181-6. doi: 10.1136/gut.21.3.181.
Zotero 插件